Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYFDA Accepts Investigational New Drug Application for CRISPR/Cas9-Based Sickle Cell Disease Therapeutic Candidate Developed Under Collaboration with Intellia TherapeuticsPREV STORYBioNTech Announces Full Year 2019 Financial Results and Corporate Update